All the news Showing 10 of 330 articles from: Access to medicines & diagnosticsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Today, the Cabinet of Ministers of Ukraine adopted the State Program to fight Hepatitis UCAB / 30 April 2013 The Diagnosis and Treatment of Hepatitis C: A Technical Landscape MSF / 26 April 2013 Conference on Hepatitis B and C in Mediterranean and Balkan Countries, report Hepatitis B & C Public Policy Association / 23 April 2013 Pakistan: Low cost Hepatitis C treatment: ‘Everything is heading in the right direction – on paper’ Express Tribune / 28 February 2013 UNITAID can address HCV/HIV co-infection The Lancet / 23 February 2013 Republic of Georgia plagued by hepatitis C Vaccine News Daily / 20 February 2013 Have a heart, save my liver! HepCoalition.org / 14 February 2013 Support Inclusion of Pegylated Interferon in the World Health Organization’s Essential Medicines List Treatment Action Group / 23 January 2013 Which patients should be prioritised for new hepatitis C treatments? Rob Camp / 23 November 2012 Younger patients with advanced liver disease caused by hepatitis C should be prioritised for treatment with newly licensed directly acting antivirals to achieve the biggest reductions in ill health and hospitalisation, according to ... Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings Michael Carter / 27 March 2012 The rollout of antiretroviral therapy in resource-limited settings provides a model for efforts to increase access to hepatitis C treatment and care in similar settings, investigators argue in the online edition of Clinical ... ← Prev1...2930313233Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive